A novel glutathione containing eicosanoid (FOG7) chemotactic for human granulocytes

被引:37
作者
Bowers, RC [1 ]
Hevko, J [1 ]
Henson, PM [1 ]
Murphy, RC [1 ]
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA
关键词
D O I
10.1074/jbc.C000502200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A biologically active glutathione adduct of the eicosanoid 5-oxo-eicosatetraenoic acid has been observed as a product formed within the murine peritoneal macrophage. This five-ore glutathione adduct (FOG(7)) was structurally characterized using electrospray tandem mass spectrometry as a 1,4 Michael addition product 5-oxo-7-glutathionyl-8,11,14-eicosatrienoic acid. FOG(7) was found to be highly potent in stimulating eosinophil as well as neutrophil chemotaxis, also capable of initiating actin polymerization, without elevating intracellular free calcium ion concentration within either the eosinophil or polymorphonuclear leukocyte. These biological responses suggest that either FOG(7) activates a subset of receptors mediating the broader biological activity of the parent eicosanoid 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) or that a receptor not activated by 5-oxo-ETE participates in the chemotactic activity of FOG(7). The only other known biologically active glutathione adduct has been leukotriene C-4 (LTC4), another eicosanoid that exerts potent effects through the Cys-LT receptor. The biochemical parallel between the formation of LTC4 and FOG(7) suggests an interesting mechanism by which biologically active eicosanoids derived from electrophilic intermediates may have unique distribution and prolonged efficacy in vivo.
引用
收藏
页码:29931 / 29934
页数:4
相关论文
共 26 条
[21]   PREPARATION AND TANDEM MASS-SPECTROMETRIC ANALYSES OF DEUTERIUM-LABELED CYSTEINE-CONTAINING LEUKOTRIENES [J].
RAFTERY, MJ ;
THORNE, GC ;
ORKISZEWSKI, RS ;
GASKELL, SJ .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1990, 19 (08) :465-474
[22]   The discovery of the leukotrienes [J].
Samuelsson, B .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (02) :S2-S6
[23]  
TALALAY P, 1989, ADV ENZYME REGUL, V28, P237, DOI 10.1016/0065-2571(89)90074-5
[24]  
Wheelan P, 1999, J PHARMACOL EXP THER, V288, P326
[25]   Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid by human monocytes and lymphocytes [J].
Zhang, Y ;
Styhler, A ;
Powell, WS .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (06) :847-854
[26]  
ZIGMOND SH, 1988, METHOD ENZYMOL, V162, P65